Determine patients’ preferences for outcomes of glaucoma surgery

  • Research type

    Research Study

  • Full title

    Exploring patients’ expectations and preferences for glaucoma surgery outcomes to facilitate healthcare promoting research

  • IRAS ID

    197945

  • Contact name

    Bina Kulkarni

  • Contact email

    Bina.Kulkarni@nuh.nhs.uk

  • Sponsor organisation

    Research & Innovation, Nottingham Health Science Partners, Nottingham University NHS Trust

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    Glaucoma is an intraocular pressure related optic neuropathy resulting in characteristic optic nerve and retinal nerve fibre damage leading to visual field loss. It is the second commonest cause for impaired vision registration over 65 years age group. Current treatment options to control the progression of glaucoma are medical and surgical treatments, which aim to lower the intraocular pressures and stabilise the visual fields. Glaucoma surgeries are important for stabilising the raised intraocular pressures and therefore preventing progression in visual field loss. The choice of surgical treatment is mainly surgeon’s preference. Although several quality of life and other qualitative researches have been performed to determine the influence of glaucoma related visual impairment on patient’s lifestyle. There is lack of knowledge regarding patients’ preferences and expectations of outcomes of the glaucoma surgery. This study hopes to bridge the gap in the qualitative research of glaucoma. This study will be conducted over a period of 1-3 years involving approximately 180 glaucoma patients. The patients will participate in focus group discussions and conjoint analysis from which themes of patient preferred outcomes will be identified and ordered in a hierarchy of importance with conjoint analysis experiment. We will specifically explore what outcomes of surgery grouped as clinical, patient centred and economic are most important to patients and to explore what outcomes should populate an audit tool for surgeons’ performances that patients will have access to in the future. The important outcome preferences identified by the patients would be used to inform the patients undergoing glaucoma surgery in the future. In addition, we will explore the minimally important clinical differences for the important outcomes identified to ensure glaucoma treatment studies are designed effectively.

  • REC name

    West Midlands - Solihull Research Ethics Committee

  • REC reference

    16/WM/0172

  • Date of REC Opinion

    14 Apr 2016

  • REC opinion

    Favourable Opinion